Jiexin Xu
Fuzhou, 350112, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Design, synthesis, and biological evaluation of pyranone-carbamate hybrids as selective butyrylcholinesterase inhibitors with anti-neuroinflammatory activity for Alzheimer's disease.
Journal: Bioorganic chemistry
Published: February 25, 2026
Converting indoprofen to moderate selective COX-2 inhibitors: Design, synthesis and biological evaluation.
Journal: Bioorganic chemistry
Published: March 27, 2025
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy.
Journal: Pharmacological research
Published: February 10, 2025
A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy.
Journal: Bioorganic chemistry
Published: January 25, 2025
Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice.
Journal: Life sciences
Published: July 11, 2024
Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer's disease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 16, 2024
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: November 21, 2022
Copper-promoted direct amidation of isoindolinone scaffolds by sodium persulfate.
Journal: Organic & biomolecular chemistry
Published: July 26, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026